Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring translational research impact requires reaching beyond current metrics.

Science translational medicine·2023
Same author

A synthetic glycosaminoglycan reduces sinonasal inflammation in a murine model of chronic rhinosinusitis.

PloS one·2018
Same author

Unusual subunits are directly involved in binding substrates for natural rubber biosynthesis in multiple plant species.

Phytochemistry·2018
Same author

IL-33 mast cell axis is central in LL-37 induced bladder inflammation and pain in a murine interstitial cystitis model.

Cytokine·2018
Same author

Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model.

American journal of clinical and experimental urology·2017
Same author

Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis.

Journal of controlled release : official journal of the Controlled Release Society·2017
Same journal

TRABD2A promotes osteogenic differentiation of human periodontal ligament stem cells by modulating TNF-α and IL-1β.

Organogenesis·2026
Same journal

Thyroid cancer-derived exosomal SPP1 promotes tumor progression by driving macrophage M2 polarization through the CD44/JAK2/STAT3 signaling pathway.

Organogenesis·2026
Same journal

MLPH/RAB3A accelerates the differentiation of pancreatic stem cells to islet β-cells to control blood glucose in diabetic rats.

Organogenesis·2026
Same journal

Adipose-derived mesenchymal stem cells-derived exosomes containing nano-pearl powder water-soluble matrix promote osteogenic differentiation of MC3T3-E1 cells.

Organogenesis·2026
Same journal

Comparison of vascular remodeling between a bioresorbable poly-L-lactic acid scaffold and a bare metal stent: a 6-month angiography and intravascular ultrasound analysis in porcine iliac arteries.

Organogenesis·2026
Same journal

Optimization of TX-100/SDS-based decellularized vascular material using ultrasound and chemical treatment: evaluation of structure and biosafety.

Organogenesis·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

Engineering a clinically-useful matrix for cell therapy.

Glenn D Prestwich1

  • 1Department of Medicinal Chemistry and Center for Therapeutic Biomaterials; University of Utah; Salt Lake City, Utah USA.

Organogenesis
|March 13, 2009
PubMed
Summary
This summary is machine-generated.

Researchers developed semi-synthetic extracellular matrices (sECMs) using hyaluronic acid for 3-D cell culture. This biomaterial supports cell therapy and tissue engineering by mimicking the native ECM for seamless in vitro to in vivo applications.

Keywords:
3-D cell culturecommercial utilitycrosslinked hydrogeldesign criteriaextracellular matrixhyaluronanregenerative medicinestem cellstissue engineering

More Related Videos

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
07:21

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

Fully Human Tumor-based Matrix in Three-dimensional Spheroid Invasion Assay
08:15

Fully Human Tumor-based Matrix in Three-dimensional Spheroid Invasion Assay

Published on: May 7, 2019

Related Experiment Videos

Last Updated: Jun 24, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
07:21

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

Fully Human Tumor-based Matrix in Three-dimensional Spheroid Invasion Assay
08:15

Fully Human Tumor-based Matrix in Three-dimensional Spheroid Invasion Assay

Published on: May 7, 2019

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Cell Biology

Background:

  • Designing matrices for cell therapy requires balancing chemical, biological, engineering, and regulatory factors.
  • Current methods struggle to replicate the native extracellular matrix (ECM) complexity for effective 3-D cell culture.
  • A biocompatible material is needed for 3-D cell culture with flexibility and seamless in vitro to in vivo transition.

Purpose of the Study:

  • To develop a biomimetic material that replicates the native ECM environment with minimal components.
  • To create a versatile and manufacturable matrix for cell therapy and tissue engineering applications.
  • To engineer a material that facilitates cell expansion and differentiation in a three-dimensional setting.

Main Methods:

  • Deconstructing the native ECM into modular components for reassembly into semi-synthetic ECMs (sECMs).
  • Utilizing thiol-modified hyaluronic acid (HA) derivatives to form covalently crosslinked, biodegradable hydrogels.
  • Incorporating biological cues to simulate tissue-specific ECM complexity within the sECMs.

Main Results:

  • Developed sECMs that are 'living' biopolymers, enabling crosslinking in the presence of cells or tissues.
  • Demonstrated the ability of sECMs to support cell therapy and tissue engineering.
  • Showcased the flexibility of sECMs to include specific biological cues for simulating native ECM complexity.

Conclusions:

  • sECM technology provides a manufacturable, reproducible, and flexible vehicle for 3-D cell expansion and differentiation.
  • The developed sECMs are biocompatible, biodegradable, and suitable for seamless transition from in vitro to in vivo use.
  • This approach offers a promising, potentially FDA-approvable, and affordable solution for cell therapy and tissue engineering.